Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells

Published:2012-04-05 Issue:7 Volume:59 Page:1245-1251
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Xie Chengzhi,Edwards Holly,LoGrasso Salvatore B.,Buck Steven A.,Matherly Larry H.,Taub Jeffrey W.,Ge Yubin

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference33 articles.

1. Cytogenetics of pediatric acute myeloid leukemia;Manola;Eur J Haematol,2009

2. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia;Meshinchi;Oncologist,2007

3. Pediatric acute myeloid leukemia: towards high-quality cure of all patients;Kaspers;Haematologica,2007

4. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia;Jeha;Blood,2004

5. Histone deacetylase inhibitors: A new perspective for the treatment of leukemia;Abujamra;Leuk Res,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo;CAN J PHYSIOL PHARM;2022

2. Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo;Canadian Journal of Physiology and Pharmacology;2022-09-01

3. c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia;Apoptosis;2022-08-09

4. Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo;CAN J PHYSIOL PHARM;2022

5. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation;Pharmaceuticals;2021-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3